Papers by Chao Meng · AgingResearch.News

Nature Medicine6 Oct
Oral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trial
Trial in peopleInterventions
Paper
Signal Transduction and Targeted Therapy14 Aug
Oral nonpeptide GLP-1 receptor agonist VCT220 for obesity treatment: a randomized, double-blind, phase II trial
Randomised trial in 250 peopleObesity
Paper
ADA Scientific Sessions 2026 Abstract6 Jun
Efficacy and Safety of a Novel Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist (HDM1002) in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Diet and Exercise or Metformin
Trial in peopleInterventions
Paper
ADA Scientific Sessions 2026 Abstract5 Jun
MDR-001, an AI-Enabled β-arrestin2-Biased Oral GLP-1RA: Efficacy and Safety in Chinese Adults with Overweight or Obesity
Trial in peopleInterventions
Paper

ADA Scientific Sessions 2025 Abstract13 Jun
Efficacy and Safety of VCT220 in Chinese Adults with Overweight or Obesity
Trial in peopleInterventions
Paper